Page last updated: 2024-11-06

prednisolone and Atypical Lipomatous Tumor

prednisolone has been researched along with Atypical Lipomatous Tumor in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogihara, T1
Inagaki, Y1
Nagata, S1
Kiryu, Y1
Miyake, S1
Shimizu, K1

Other Studies

1 other study available for prednisolone and Atypical Lipomatous Tumor

ArticleYear
Combination chemotherapy in retroperitoneal poorly differentiated myxoid liposarcoma: a report of a case.
    Japanese journal of medicine, 1983, Volume: 22, Issue:1

    Topics: Antineoplastic Agents; Constriction, Pathologic; Cyclophosphamide; Dactinomycin; Diabetes Mellitus;

1983